NCT02549365View on ClinicalTrials.gov

Efficacy & Safety of Nasal Influenza Immunisation in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Influenza Vaccines Efficacy and Safety
Interventions
DRUG

Live attenuated influenza vaccine

Administration of LAIV, with subsequent surveillance (nasal swabbing) during influenza season

PROCEDURE

Surveillance (nasal swabbing) during influenza season

Trial Locations (1)

W2 1NY

Imperial College London / Imperial College Healthcare NHS Trust, London

All Listed Sponsors
collaborator

Public Health England

OTHER_GOV

lead

Imperial College London

OTHER

NCT02549365 - Efficacy & Safety of Nasal Influenza Immunisation in Children | Biotech Hunter | Biotech Hunter